A control program for the cardiopulmonary resuscitation device has been registered at Penza State University (PSU). The adaptive system will collect data about the patient’s condition and provide continuous chest compressions with sternal compression at adjustable frequency and depth. The Ministry of Education and Science of the Russian Federation told socialbites.ca about this.
Cardiopulmonary resuscitation device is used when a person has cardiac arrest and can restart the heart, thus restoring blood circulation in the body.
“The device is designed to replace the physical work of a healthcare worker for the entire period of resuscitation. It will perform continuous automatic chest compressions at a preset frequency and compression depth. It monitors and recognizes lack of breathing and blood circulation. Program developer Kirill Ilyin told socialbites.ca If a critical situation arises, the device will start performing chest compressions, artificial respiration and intensive therapy, he said in a statement.
For the device to work properly, it is necessary to monitor patient parameters, such as movement of the sternum surface, compression frequency, carbon dioxide pressure during exhalation, pulse rate and other indicators during resuscitation. They are controlled by a control program that runs using a tachometer put together by PSU scientists. The tachometer itself is mounted on the body of the device and measures the number of times the device mechanism presses on the patient’s chest per minute.
“The prototype is a tachometer whose “brain” is the control program we wrote, adapted to a specific situation, controlling the frequency of chest compressions by the device mechanism. We taught him certain algorithms so that he can properly provide emergency care to a patient,” says Ilyin.
In addition, when necessary, the program can wirelessly transmit the collected information to the hospital where the doctor is waiting for the patient. This will help quickly and competently provide assistance while in the ambulance and, if necessary, pre-prepare the intensive care unit for surgical intervention.
Previously in Russia was created Natural glass analogues for drug delivery.